
Medicare to Cover Ozempic and Other Weight Loss Drugs, Lowering Costs
President Trump announced a deal to expand Medicare coverage for weight-loss drugs like Ozempic and Wegovy, reducing costs for beneficiaries and potentially increasing federal spending by at least $35 billion from 2026 to 2034, amid ongoing concerns about the national debt.













